Neuromuscular Disorder-Targeting Compound 1

CAT:

804-HY-U00385

Size:

Inquire

Price:

Ask

For price, please contact [email protected]

CAS Number: 374538-23-5
UNSPSC Description: Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome.
Target Antigen: Others
Type: Reference compound
Related Pathways: Others
Applications: Neuroscience-Neuromodulation
Field of Research: Neurological Disease
Assay Protocol: https://www.medchemexpress.com/1H-Pyrazolo[3,4-g]quinoline,_4,4a,5,6,7,8,8a,9-octahydro-7-[_methylthio_methyl]-5-propyl-,__4aR,8aR_-rel-.html
Solubility: 10 mM in DMSO
Smiles: CCCN1CC(CSC)C[C@]2([H])CC(NN=C3)=C3C[C@@]12[H]
Molecular Weight: 279.44
References & Citations: [1]Robertson, David W., et al. TREATMENT OF FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME. WO 2001087308 A1.
Shipping Conditions: Room temperature
Clinical Information: No Development Reported

Cat	Name
HY-U00385	Neuromuscular Disorder-Targeting Compound 1
HY-U00310	Neuromuscular-targeting compound 1
HY-U00362	Neurodegenerative Disorder-Targeting Compound 1
HY-U00362A	(Rac)-Neurodegenerative Disorder-Targeting Compound 1
HY-U00393	Arrhythmic-Targeting Compound 1
HY-101750	Arrhythmias-Targeting Compound 1
HY-U00361	Itch-Targeting Compound 1
HY-U00300	Cancer-Targeting Compound 1
HY-U00357	Urinary Incontinence-Targeting Compound 1
HY-P10055	PSMA targeting peptide

Cat	Name
T10059-10mg	Neuromuscular Disorder-Targeting Compound 1
T10059-1mg	Neuromuscular Disorder-Targeting Compound 1
T10059-50mg	Neuromuscular Disorder-Targeting Compound 1
T10059-5mg	Neuromuscular Disorder-Targeting Compound 1
T10059-1g	Neuromuscular Disorder-Targeting Compound 1
MBS5765872	Neuromuscular Disorder-Targeting Compound 1
T13491-1g	Neuromuscular-targeting compound 1
T13491-10mg	Neuromuscular-targeting compound 1
MBS5767935	Neuromuscular-targeting compound 1
T13491-1mg	Neuromuscular-targeting compound 1